Atlas Trials

Medico-economic Evaluation Comparing the Impact of the New Fixed-dose Nivolumab Regimen With the Old mg/kg Regimen in the Management of Patients With Metastatic Cancer

Clinical trial NCT05380336 · COMPLETED

Trial details

NCT number
NCT05380336
Sponsor
Nantes University Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Cancer
Start date
2014-01-01
Primary completion
2021-12-31
Enrollment
40000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.